Skip to main content

Levetiracetam

NDC 68094-313 · Precision Dose, Inc.

Generic namelevetiracetam
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)LEVETIRACETAM
Strength100 mg/mL
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

68094-313-10 — 10 VIAL, SINGLE-USE in 1 CARTON (68094-313-10) / 5 mL in 1 VIAL, SINGLE-USE

68094-313-25 — 25 VIAL, SINGLE-USE in 1 CARTON (68094-313-25) / 5 mL in 1 VIAL, SINGLE-USE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68001-114 — Levetiracetam, 68001-402 — Levetiracetam, 68001-403 — Levetiracetam, 68001-404 — Levetiracetam, 68001-405 — Levetiracetam, 68083-152 — Levetiracetam, 68083-153 — Levetiracetam, 68083-154 — Levetiracetam, 68084-859 — Levetiracetam, 68084-882 — Levetiracetam, 68180-112 — Levetiracetam, 68180-113 — Levetiracetam, 68180-114 — Levetiracetam, 68180-115 — Levetiracetam, 68180-117 — Levetiracetam, 68180-118 — Levetiracetam, 68788-7884 — Levetiracetam, 68788-8254 — Levetiracetam, 68788-8843 — Levetiracetam, 68999-548 — LEVETIRACETAM, +277 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels